Largest health care pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 health care pharmaceutical companies ranked by total liabilities, at DKK 934.1B, ahead of Pfizer (DKK 826.5B) and Johnson & Johnson (DKK 801.2B). Figures as of 19 Nov 2026, 20:53 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieDKK 934.1B
- Median
- DKK 14.2B
- Combined market value
- DKK 33.83T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | DKK 934.1B | DKK 3.41T | DKK 1,931.29 | 0.83% down | 25% up | ||
| 2 | PfizerPFE · Health Care | DKK 826.5B | DKK 1.07T | DKK 187.86 | 1.67% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | DKK 801.2B | DKK 4.38T | DKK 1,819.04 | 2.04% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | DKK 585.2B | DKK 8.2T | DKK 9,209.12 | 2.19% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | DKK 573.4B | DKK 2.23T | DKK 905.81 | 3.45% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | DKK 487.1B | DKK 812.7B | DKK 397.58 | 1.96% down | 30% up | ||
| 7 | AstraZenecaAZN · Health Care | DKK 445B | DKK 1.85T | DKK 1,194.17 | 1.89% down | 1% up | ||
| 8 | NovartisNVS · Health Care | DKK 438.5B | DKK 1.95T | DKK 1,031.10 | 2.44% down | 25% up | ||
| 9 | SanofiSNY · Health Care | DKK 416.2B | DKK 753.2B | DKK 313.66 | 2.24% down | 4% down | ||
| 10 | GSKGSK · Health Care | DKK 408.2B | DKK 653.2B | DKK 325.85 | 1.49% down | 5% up | ||
| 11 | Novo NordiskNVO · Health Care | DKK 352.5B | DKK 1.17T | DKK 264.91 | 1.33% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | DKK 344.6B | DKK 467.2B | DKK 146.22 | 0.96% up | 51% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | DKK 231.1B | DKK 1.23T | DKK 709.71 | 0.24% down | 16% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 223.6B | DKK 308.5B | DKK 264.43 | 8.04% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | DKK 153.1B | DKK 155.3B | DKK 135.43 | 1.92% down | 99% up | ||
| 16 | GrifolsGRFS · Health Care | DKK 91.5B | DKK 38.1B | DKK 56.00 | 2.89% down | 0% up | ||
| 17 | ZoetisZTS · Health Care | DKK 82.6B | DKK 224.5B | DKK 552.56 | 5.17% down | 26% down | ||
| 18 | Royalty PharmaRPRX · Health Care | DKK 67.4B | DKK 265.1B | DKK 460.97 | 1.41% down | 79% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | DKK 63.3B | DKK 653.7B | DKK 6,319.59 | 1.84% down | 28% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 50B | DKK 102.7B | DKK 1,599.72 | 5.18% down | 41% up | ||
| 21 | GenmabGMAB · Health Care | DKK 47.8B | DKK 215.4B | DKK 349.41 | 0.68% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | DKK 47.5B | DKK 901.7B | DKK 3,556.44 | 2.64% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | DKK 46.4B | DKK 90.2B | DKK 180.47 | 0.73% down | 26% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | DKK 28.4B | DKK 135.3B | DKK 1,010.40 | 0.68% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | DKK 26.1B | DKK 311.2B | DKK 2,724.44 | 0.86% down | 16% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25B | DKK 50.6B | DKK 145.37 | 2.42% down | 90% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | DKK 21.1B | DKK 33.3B | DKK 398.81 | 2.76% down | 21% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | DKK 20.7B | DKK 31B | DKK 185.96 | 0.29% down | 63% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | DKK 20.5B | DKK 104B | DKK 533.90 | 0.51% up | 21% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 14.4B | DKK 84.6B | DKK 101.45 | 0.53% down | 8% up | ||
| 31 | CytokineticsCYTK · Health Care | DKK 14.2B | DKK 48.9B | DKK 351.35 | 0.55% up | 19% down | ||
| 32 | Ascendis PharmaASND · Health Care | DKK 11.1B | DKK 114.2B | DKK 1,741.69 | 5.38% down | 29% up | ||
| 33 | InsmedINSM · Health Care | DKK 10.4B | DKK 215.8B | DKK 983.74 | 20.60% up | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | DKK 10.3B | DKK 81.2B | DKK 419.17 | 0.21% up | 17% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 6B | DKK 42.1B | DKK 298.10 | 1.55% up | 13% up | ||
| 36 | United TherapeuticsUTHR · Health Care | DKK 5.3B | DKK 162.9B | DKK 3,825.06 | 2.70% down | 22% up | ||
| 37 | Legend BiotechLEGN · Health Care | DKK 5B | DKK 21.3B | DKK 110.03 | 0.55% down | 41% down | ||
| 38 | AlkermesALKS · Health Care | DKK 4.5B | DKK 53B | DKK 315.12 | 1.22% down | 66% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 4.5B | DKK 62.9B | DKK 2,708.90 | 0.06% down | 27% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | DKK 4.1B | DKK 48.7B | DKK 926.20 | 1.51% up | 6% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | DKK 3.7B | DKK 39.3B | DKK 1,965.81 | 3.35% down | 50% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | DKK 3.6B | DKK 42.5B | DKK 650.54 | 3.30% up | 34% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | DKK 3.3B | DKK 31.7B | DKK 330.41 | 3.41% down | 45% up | ||
| 44 | Roivant SciencesROIV · Health Care | DKK 2.8B | DKK 193.5B | DKK 267.12 | 1.29% up | 91% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | DKK 2.8B | DKK 67.3B | DKK 445.04 | 1.15% down | 117% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | DKK 2.1B | DKK 33.1B | DKK 190.48 | 0.59% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 1.4B | DKK 55.5B | DKK 800.75 | 1.21% down | 18% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 1.3B | DKK 50.3B | DKK 639.92 | 1.13% down | 129% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | DKK 1.3B | DKK 48.6B | DKK 443.68 | 3.88% down | 10% down | ||
| 50 | ABIVAXABVX · Health Care | DKK 975.6M | DKK 48.2B | DKK 550.21 | 3.61% down | 32% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | DKK 733.8M | DKK 27.6B | DKK 201.62 | 1.68% up | 168% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | DKK 628.6M | DKK 58.1B | DKK 72.65 | 1.62% up | 36% down | ||
| 53 | ErascaERAS · Health Care | DKK 483.3M | DKK 34.4B | DKK 98.12 | 4.72% up | 395% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | DKK 425.9M | DKK 63.6B | DKK 669.67 | 3.07% down | 332% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | DKK 407M | DKK 60B | DKK 2,146.05 | 3.27% up | 86% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | DKK 364.2M | DKK 55.8B | DKK 854.54 | 1.31% down | 51% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | DKK 255.5M | DKK 32.7B | DKK 581.02 | 1.61% up | 108% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | DKK 206.6M | DKK 30.7B | DKK 280.50 | 0.42% down | 86% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | DKK 113.6M | DKK 45.3B | DKK 668.41 | 2.53% up | 255% up | ||
| 60 | Belite BioBLTE · Health Care | DKK 68.6M | DKK 42.2B | DKK 1,039.71 | 2.26% down | 43% up | ||
| 61 | VeradermicsMANE · Health Care | DKK 62.3M | DKK 35.9B | DKK 849.74 | 0.05% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8091 DKK).
Questions and answers
Which health care pharmaceutical companies rank first by total liabilities?
AbbVie (DKK 934.1B), Pfizer (DKK 826.5B) and Johnson & Johnson (DKK 801.2B) are the top three of the 61 health care pharmaceutical companies ranked by total liabilities as of 19 Nov 2026, 20:53 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total liabilities have a combined market value of DKK 33.83T as of 19 Nov 2026, 20:53 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.